
Shanzhiside methyl ester
CAS No. 64421-28-9
Shanzhiside methyl ester( —— )
Catalog No. M18948 CAS No. 64421-28-9
Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 58 | In Stock |
![]() ![]() |
10MG | 103 | In Stock |
![]() ![]() |
25MG | 190 | In Stock |
![]() ![]() |
50MG | 283 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameShanzhiside methyl ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionShanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
-
DescriptionShanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
-
In Vitro——
-
In VivoShanzhiside methyl ester exerts dose-dependent and long-lasting (>4 h) anti-allodynic effects in spinal nerve injury-induced neuropathic rats, with a maximal inhibition of 49% and a projected ED50 of 40.4 μg.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorGLP-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64421-28-9
-
Formula Weight406.38
-
Molecular FormulaC17H26O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (246.08 mM)
-
SMILES[C@@H]1([C@H]2[C@@H](C(=CO1)C(=O)OC)[C@@H](C[C@]2(C)O)O)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fan PC,et al. Biomed Chromatogr. 2012 Dec;26(12):1543-51.
molnova catalog



related products
-
VAL-083
VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
JH-RE-06
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
-
Dacarbazine
Dacarbazine(DTIC-Dome) is an antineoplastic chemotherapy drug used in the treatment of various Ys, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas.